N V Nhung1, N B Hoa2, D N Sy3, C M Hennig4, A S Dean5. 1. National Tuberculosis Programme Viet Nam, Hanoi, Viet Nam; Viet Nam Association for Tuberculosis and Lung Disease, Hanoi, Viet Nam. 2. National Tuberculosis Programme Viet Nam, Hanoi, Viet Nam; Centre for Operational Research, International Union Against Tuberculosis and Lung Disease, Paris, France. 3. Viet Nam Association for Tuberculosis and Lung Disease, Hanoi, Viet Nam. 4. World Health Organization (WHO) Regional Office for the Western Pacific, Manila, The Philippines. 5. Global Tuberculosis Programme, WHO, Geneva, Switzerland.
Abstract
SETTING: Viet Nam's Fourth National Anti-Tuberculosis Drug Resistance Survey was conducted in 2011. OBJECTIVE: To determine the prevalence of resistance to the four main first-line anti-tuberculosis drugs in Viet Nam. METHODS: Eighty clusters were selected using a probability proportion to size approach. Drug susceptibility testing (DST) against the four main first-line anti-tuberculosis drugs was performed. RESULTS: A total of 1629 smear-positive tuberculosis (TB) patients were eligible for culture. Of these, DST results were available for 1312 patients, including 1105 new TB cases, 195 previously treated TB cases and 12 cases with an unknown treatment history. The proportion of cases with resistance to any drug was 32.7% (95%CI 29.1-36.5) among new cases and 54.2% (95%CI 44.3-63.7) among previously treated cases. The proportion of multidrug-resistant TB (MDR-TB) cases was 4.0% (95%CI 2.5-5.4) in new cases and 23.3 (95%CI 16.7-29.9) in previously treated cases. CONCLUSIONS: The fourth drug resistance survey in Viet Nam found that the proportion of MDR-TB among new and previously treated cases was not significantly different from that in the 2005 survey. The National TB Programme should prioritise the detection and treatment of MDR-TB to reduce transmission of MDR-TB in the community.
SETTING: Viet Nam's Fourth National Anti-Tuberculosis Drug Resistance Survey was conducted in 2011. OBJECTIVE: To determine the prevalence of resistance to the four main first-line anti-tuberculosis drugs in Viet Nam. METHODS: Eighty clusters were selected using a probability proportion to size approach. Drug susceptibility testing (DST) against the four main first-line anti-tuberculosis drugs was performed. RESULTS: A total of 1629 smear-positive tuberculosis (TB) patients were eligible for culture. Of these, DST results were available for 1312 patients, including 1105 new TB cases, 195 previously treated TB cases and 12 cases with an unknown treatment history. The proportion of cases with resistance to any drug was 32.7% (95%CI 29.1-36.5) among new cases and 54.2% (95%CI 44.3-63.7) among previously treated cases. The proportion of multidrug-resistant TB (MDR-TB) cases was 4.0% (95%CI 2.5-5.4) in new cases and 23.3 (95%CI 16.7-29.9) in previously treated cases. CONCLUSIONS: The fourth drug resistance survey in Viet Nam found that the proportion of MDR-TB among new and previously treated cases was not significantly different from that in the 2005 survey. The National TB Programme should prioritise the detection and treatment of MDR-TB to reduce transmission of MDR-TB in the community.
Authors: N Quispe; L Asencios; C Obregon; G E Velásquez; C D Mitnick; M Lindeborg; H Jave; L Solari Journal: Int J Tuberc Lung Dis Date: 2020-02-01 Impact factor: 2.373
Authors: Van Anh Thi Nguyen; Anne-Laure Bañuls; Thanh Hoa Thi Tran; Kim Lien Thi Pham; Thai Son Nguyen; Hung Van Nguyen; Ngoc Lan Thi Nguyen; Nam Lien Thi Nguyen; Duc Anh Dang; Guy B Marks; Marc Choisy Journal: BMC Microbiol Date: 2016-07-28 Impact factor: 3.605
Authors: Phillip P Salvatore; Emily A Kendall; Dena Seabrook; Jessie Brown; George H Durham; David W Dowdy Journal: Sci Rep Date: 2019-12-02 Impact factor: 4.379
Authors: Le Hong Van; Phan Trieu Phu; Dao Nguyen Vinh; Vo Thanh Son; Nguyen Thi Hanh; Le Thanh Hoang Nhat; Nguyen Huu Lan; Truong Van Vinh; Nguyen Thi Mai Trang; Dang Thi Minh Ha; Guy E Thwaites; Nguyen Thuy Thuong Thuong Journal: BMC Infect Dis Date: 2020-02-22 Impact factor: 3.090